Paul Schimmel, Director at Alnylam Pharma, holds 1.10M shares in aTyr Pharma (Ticker: ATYR), holds 307.00K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Forte Biosciences (Ticker: FBRX). Most recently, Paul Schimmel Bought ― shares of aTyr Pharma on Jul 24, 2024 for an estimated value of 184.40K.
What is the percentage of profitable transactions made by Paul Schimmel?
The percentage of profitable transactions made by Paul Schimmel is 20%.
What is the average return per transaction made by Paul Schimmel?
The average return per transaction made by Paul Schimmel is -30.90%.
What stocks does Paul Schimmel hold?
Paul Schimmel holds: ALNY, ATYR, FBRX, RGEN stocks.
What was Paul Schimmel’s latest transaction?
Paul Schimmel latest transaction was an Informative Buy of $184.40K.
What was Paul Schimmel's most profitable transaction?
Paul Schimmel’s most profitable transaction was an Informative Buy of ATYR stock on July 24, 2024. The return on the trade was 61.60%.
What is Paul Schimmel's role in Alnylam Pharma?
Paul Schimmel's role in Alnylam Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.